OSSIO received FDA 510(k) clearance to market OSSIOfiber bone pins, made of a bio-integrative material designed to provide stability and secure bone fixation that will leave no hardware behind.
Trice Medical closed a US $18.3MM Series C Extension financing round. Funds will support worldwide commercialization of mi-eye 2 and mi-ultra minimally invasive orthopaedic diagnostic tools, as well as product development.
Generex Biotechnology entered into letters of intent to acquire Pantheon Medical “ Foot & Ankle, manufacturer of the FDA-cleared Balanced Plating System, and distributor Medisource Partners.